Skip to content

XOMA Corporation XOMA Restricted Cash

Restricted Cash at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$17K
Theravance Biopharma logo
Theravance BiopharmaTBPH
$836K0.0%
ALN
Alnylam PharmaceuticalsALNY
$1.64M-36.8%
Xencor logo
XencorXNCR
$191K-32.7%
Roivant Sciences logo
Roivant SciencesROIV
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's restricted cash?
XOMA Corporation (XOMA) reported restricted cash of $8.86M in Q1 2026.
How has XOMA Corporation's restricted cash changed year-over-year?
XOMA Corporation's restricted cash increased by 528.5% year-over-year, from $1.41M to $8.86M.
What is the long-term trend for XOMA Corporation's restricted cash?
Over 4 years (2020 to 2025), XOMA Corporation's restricted cash has grown at a 35.6% compound annual growth rate (CAGR), from $1.61M to $5.44M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.